BANK OF AMERICA CORP /DE/
BankPosition in RVMD — Revolution Medicines, Inc.
CIK 70858
CHARLOTTE, NC
Position in RVMD
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$59,726,766
-$10,352,885 QoQ
Shares Held
614,157
-30.2% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 71.75901276058076.ToString("F0")%
Shared 0.ToString("F0")%
None 28.240987239419233.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Sep 30, 2023CallValue
$4,196,288
CallShares
151,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,405,235 across 346 Biotechnology names. RVMD ranks #36 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in RVMD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,726,766 | 614,157 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $70,079,651 | 879,845 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $35,205,586 | 753,867 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $21,216,165 | 576,683 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,790,429 | 446,562 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $17,541,617 | 401,043 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $19,415,150 | 428,118 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,546,003 | 400,567 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $17,535,890 | 544,086 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,055,478 | 246,007 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,671,690 | 168,775 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $4,196,288 | 151,600 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $5,844,366 | 218,481 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $20,397,936 | 941,733 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $10,514,504 | 441,415 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $4,286,693 | 217,378 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,055,375 | 105,458 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,371,767 | 210,575 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $818,174 | 32,506 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $560,019 | 20,357 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $902,463 | 28,433 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $582,721 | 12,701 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $366,563 | 9,259 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $353,811 | 10,167 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $196,017 | 6,209 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $312,764 | 14,275 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||